These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1401 related articles for article (PubMed ID: 28284757)

  • 1. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
    Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
    Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats.
    Ishikane S; Hosoda H; Yamahara K; Akitake Y; Kyoungsook J; Mishima K; Iwasaki K; Fujiwara M; Miyazato M; Kangawa K; Ikeda T
    Transplantation; 2013 Oct; 96(8):697-706. PubMed ID: 23912174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracardiac-Lodged Mesenchymal Stromal Cells Propel an Inflammatory Response Against Myocardial Infarction via Paracrine Effects.
    Peng Y; Pan W; Ou Y; Xu W; Kaelber S; Borlongan CV; Sun M; Yu G
    Cell Transplant; 2016; 25(5):929-35. PubMed ID: 26498018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair.
    Oskouei BN; Lamirault G; Joseph C; Treuer AV; Landa S; Da Silva J; Hatzistergos K; Dauer M; Balkan W; McNiece I; Hare JM
    Stem Cells Transl Med; 2012 Feb; 1(2):116-24. PubMed ID: 23197758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
    Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
    Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.
    Williams AR; Hatzistergos KE; Addicott B; McCall F; Carvalho D; Suncion V; Morales AR; Da Silva J; Sussman MA; Heldman AW; Hare JM
    Circulation; 2013 Jan; 127(2):213-23. PubMed ID: 23224061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.
    Zhao L; Liu X; Zhang Y; Liang X; Ding Y; Xu Y; Fang Z; Zhang F
    Exp Cell Res; 2016 May; 344(1):30-39. PubMed ID: 27025401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction.
    Tang YL; Zhao Q; Qin X; Shen L; Cheng L; Ge J; Phillips MI
    Ann Thorac Surg; 2005 Jul; 80(1):229-36; discussion 236-7. PubMed ID: 15975372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction.
    Shafei AE; Ali MA; Ghanem HG; Shehata AI; Abdelgawad AA; Handal HR; Talaat KA; Ashaal AE; El-Shal AS
    J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29044850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.
    Hu X; Xu Y; Zhong Z; Wu Y; Zhao J; Wang Y; Cheng H; Kong M; Zhang F; Chen Q; Sun J; Li Q; Jin J; Li Q; Chen L; Wang C; Zhan H; Fan Y; Yang Q; Yu L; Wu R; Liang J; Zhu J; Wang Y; Jin Y; Lin Y; Yang F; Jia L; Zhu W; Chen J; Yu H; Zhang J; Wang J
    Circ Res; 2016 Mar; 118(6):970-83. PubMed ID: 26838793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction.
    Yao X; Liu Y; Gao J; Yang L; Mao D; Stefanitsch C; Li Y; Zhang J; Ou L; Kong D; Zhao Q; Li Z
    Biomaterials; 2015 Aug; 60():130-40. PubMed ID: 25988728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed enrichment for c-kit and inducing cardiac differentiation attenuated protective effects of BMSCs' transplantation in pig model of acute myocardial ischemia.
    Zhang GW; Gu TX; Guan XY; Sun XJ; Jiang DQ; Tang R; Qi X; Li XY
    Cardiovasc Ther; 2015 Aug; 33(4):184-92. PubMed ID: 25959676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necroptosis Induced by Ad-HGF Activates Endogenous C-Kit+ Cardiac Stem Cells and Promotes Cardiomyocyte Proliferation and Angiogenesis in the Infarcted Aged Heart.
    Liu J; Wu P; Wang H; Wang Y; Du Y; Cheng W; Xu Z; Zhou N; Wang L; Yang Z
    Cell Physiol Biochem; 2016; 40(5):847-860. PubMed ID: 27941320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Endogenous Cardiac Stem Cells by Apelin-13 in Infarcted Rat Heart.
    Zhang NK; Cao Y; Zhu ZM; Zheng N; Wang L; Xu XH; Gao LR
    Cell Transplant; 2016; 25(9):1645-1652. PubMed ID: 26924778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of NUCKS augments paracrine effects of mesenchymal stem cells-mediated cardiac protection.
    Zhang Y; Chiu S; Liang X; Chai YH; Qin Y; Wang J; Li X; Qiu B; Tergaonkar V; Tse HF; Lian Q
    Exp Cell Res; 2017 Jul; 356(1):74-84. PubMed ID: 28412246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms.
    Santos Nascimento D; Mosqueira D; Sousa LM; Teixeira M; Filipe M; Resende TP; Araújo AF; Valente M; Almeida J; Martins JP; Santos JM; Bárcia RN; Cruz P; Cruz H; Pinto-do-Ó P
    Stem Cell Res Ther; 2014 Jan; 5(1):5. PubMed ID: 24411922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.